Astera Labs, Inc. Common Stock (ALAB) Stock Analysis
Market Closed
Sector: Technology · Industry: Semiconductors & Related Devices
What's happening with ALAB
Price History
5-Year Weekly Candlestick Chart
Profile
Strong financial health and profitability; valuation and earnings quality lag behind.
How is each axis scored?
- Valuation15/100 · Weak
- P/E vs own history (87th pct)0/25
- FCF yield (0.6%)5/25
- P/S (59.2x)0/25
- EV/EBIT (n/a)10/25
- Growth50/100 · Moderate
- Revenue CAGR (115.1%)25/25
- Net income CAGR (n/a)0/25
- EPS CAGR 5Y (n/a)0/25
- Fwd implied growth (196.6%)25/25
- Profitability90/100 · Strong
- ROIC (57.2%)25/25
- ROE (17.9%)20/25
- Net margin (26.7%)25/25
- Operating margin (22.4%)20/25
- Financial Health100/100 · Strong
- Altman Z (225.92)25/25
- Current ratio (11.30)25/25
- Interest coverage (no interest expense)25/25
- Net cash / debt (Net cash)25/25
- Quality46/100 · Weak
- Piotroski F (5/9)15/25
- Beneish M (1.26)0/25
- FCF conversion (128%)25/25
- Margin stability (σ 24.9%)6/25
About Astera Labs, Inc. Common Stock
Astera Labs Inc designs and delivers semiconductor-based connectivity solutions for cloud and AI infrastructure. Show more
Its Intelligent Connectivity Platform integrates semiconductor technology, microcontrollers, sensors, and software to enhance performance, scalability, and data management. The company offers products such as integrated circuits (ICs), boards, and modules, catering to hyperscalers and system OEMs. The company's solutions focus on data, network, and memory management in AI-driven platforms. Geographically, the company operates in Singapore, China, Taiwan, and United States, of which maximum revenue is derived from United States.
Headquarters: SAN JOSE, CA · Employees: 756 · Website ↗
Analyst Consensus
Strong BuyWall Street consensus estimates — not a PMP forecast · Updated Sep 21, 2026
Insider Transactions
Recent SEC Form 4 filings
- SellOpen market sale · filed 2026-08-10-416 sh2026-08-06
- SellOpen market sale · filed 2026-08-10-5246 sh2026-08-06
- SellOpen market sale · filed 2026-08-10-2207 sh2026-08-06
- SellOpen market sale · filed 2026-08-10-51 sh2026-08-06
- SellOpen market sale · filed 2026-08-10-640 sh2026-08-06
+3 more recent filings
Key Metrics
Financial snapshot — pillar inputs plus per-share and market context
Valuation
15EP/E (TTM)231.2xD
Grade D: Exp.Price / TTM EPS (own statements) — vs own 3Y history: 72.0x–327.0x · 87th pct
P/FCF213.7xD
Grade D: Exp.Price / Free Cash Flow per share (Finnhub). Inverse of FCF yield — negative when FCF is negative
FCF Yield0.6%C
Grade C: LowTTM FCF / Market Cap — vs own 3Y history: 0.2%–1.8% · 18th pct
P/S (TTM)59.16xD
Grade D: Exp.Price / TTM Revenue (own statements) — vs own 3Y history: 17.3x–113.3x · 86th pct
EV/EBITDA206.7xD
Grade D: Exp.Enterprise value / EBITDA (Finnhub) — capital-structure neutral
EV/Sales49.1xD
Grade D: V.Exp.Enterprise Value / TTM Revenue (Finnhub) — capital-structure neutral sales multiple
Forward P/E77.9xD
Grade D: Exp.Price / next-year EPS estimate — shows whether the TTM multiple is rich or just front-loading growth
P/B Ratio39.66xD
Grade D: V.Exp.Price to Book Value. Neg. equity = heavy buybacks
PEG Ratio5.34D
Grade D: Exp.Finnhub PEG — their P/E basis ÷ expected EPS growth. Suppressed when their P/E diverges >2× from our TTM P/E (different basis)
Dividend Yield—
TTM dividend yield (Finnhub) — annual dividends / price. None = no dividend; very high yield can signal distress
Payout Ratio—
Dividends / Net Income (Finnhub) — share of earnings paid out; >90% or negative = unsustainable
Profitability
90A+ROIC57.2%A
Grade A: MoatNOPAT (EBIT less ~21% tax) / invested capital (equity + debt − cash). Flagship quality metric — durable >15% signals a moat
ROE17.9%C
Grade C: AvgReturn on Equity. Neg. equity = heavy buybacks
ROA22.7%A
Grade A: StrongReturn on Assets (Finnhub) — Net Income / Total Assets; how efficiently assets produce profit
Net Margin26.7%A
Grade A: HighNet Income / Revenue
Operating Margin22.4%C
Grade C: AvgTTM EBIT / TTM Revenue
Gross Margin76.0%A
Grade A: PremiumGross Profit / Revenue
FCF Margin34.2%A
Grade A: HighFCF / Revenue
True FCF Margin17.6%A
Grade A: HighTTM (OCF − CapEx − SBC) / TTM Revenue — SBC treated as a real cost
Financial Health
100A+Altman Z-Score225.92A
Grade A: SafeBankruptcy risk. >3 Safe, <1.8 Distress
Current Ratio11.30xA
Grade A: HighCurrent Assets/Liabilities
Quick Ratio9.56xA
Grade A: High(Current Assets − Inventory) / Current Liabilities (Finnhub) — stricter liquidity test, excludes inventory
Interest Coverage—
EBIT/Interest. >10 Strong
Debt RepaymentNet CashA
Grade A: FastYears to repay net debt via FCF
Net Debt/EBIT—
Leverage. <2x Low, >4x High
Debt/Equity0.00xA
Grade A: LowDebt / Equity: <1 Conservative, >2 Risky. Not meaningful with non-positive equity; shown as unavailable rather than low debt.
Cash / Debt—
Cash covers how much of total debt. >1 = could repay all debt from cash
Growth
50CRevenue CAGR115.1%A
Grade A: HighCompound annual revenue growth (up to 5Y depending on data availability)
Net Income CAGR—
Compound annual net income growth (up to 5Y depending on data availability)
EPS CAGR (5Y)—
Compound annual EPS growth over up to 5Y of per-share earnings (own statements). Null when either endpoint EPS ≤ 0
Forward Growth196.6%A
Grade A: HighImplied 1Y EPS growth from forward P/E vs our TTM EPS. Sparse — only where forward estimates exist
Dilution (5Y)—
Share count change over 5Y
SBC / Net Income62.2%D
Grade D: HighStock-based comp/Net income. >30% = dilution risk
SBC / Revenue16.6%D
Grade D: HighTTM stock-based comp / TTM Revenue
Quality
1/2 Loss Years46D+Piotroski F-Score5/9C
Grade C: AvgFinancial strength 0–9. >7 Strong
Beneish M-Score1.26D
Grade D: RiskyEarnings manipulation risk. < -2.22 Safe
FCF Conversion128.1%A
Grade A: StrongFCF / Net Income
Margin Stability24.9%D
Grade D: VolatileEBIT margin std deviation. Lower = stable
Capex / Revenue4.1%A
Grade A: Asset-lightTTM CapEx / TTM Revenue — high % = capital-hungry business
Asset Turnover0.56xC
Grade C: AvgRevenue / Total Assets (Finnhub) — how efficiently the asset base generates sales
Per Share
EPS (TTM)$1.48
Own TTM net income / shares — same earnings basis as P/E
Cash / Share$6.99
Cash & short-term investments per share (Finnhub)
Book Value / Share$8.01
Shareholders' equity per share (Finnhub). Negative = accumulated losses / heavy buybacks
Balance Sheet
Total Debt—
Total debt obligations (short + long term)
Cash & Equiv.$1.18B
Cash and short-term investments
Net Debt—
Total Debt minus Cash. Negative = Net Cash position
Total Equity$1.49B
Shareholders' equity (book value)
Asset / Liability10.04xA
Grade A: SolidTotal Assets / Total Liabilities
Market
Market Cap$59.25B
Current Market Capitalization
Beta3.82D
Grade D: H.VolPrice sensitivity vs the market (Finnhub) — 1.0 moves with market, >1.2 amplifies swings
Takeaway
Mimoriadne finančné zdravie a vysokú ziskovosť spoločnosti ALAB aktuálne znehodnocuje extrémne drahé ocenenie s FCF výnosom na úrovni iba 0,6 %.
Company is effectively debt-free after netting cash. · Current P/E of 231.2x sits at the 87th percentile of its historical range.
How grades work: each metric is graded A–D against fixed thresholds (tap a row for the meaning). Card grades map the pillar score to A+–E — a card grade is that pillar's own score, not an average of the rows shown.
Financials as of Mar 2026 · Ratio snapshot Sep 22, 2026
Key Insights: Astera Labs, Inc. Common Stock (ALAB)
Composite verdict for Astera Labs, Inc. Common Stock: Mimoriadne finančné zdravie a vysokú ziskovosť spoločnosti ALAB aktuálne znehodnocuje extrémne drahé ocenenie s FCF výnosom na úrovni iba 0,6 %.. Piotroski F-Score of 5/9 indicates mixed fundamentals for Astera Labs, Inc. Common Stock. Altman Z-Score of 225.92 sits comfortably in the safe zone (≥ 2.99), indicating low bankruptcy risk. Beneish M-Score of 1.26 is above the −1.78 flag threshold, a signal that reported earnings warrant closer scrutiny. Revenue has compounded at roughly 115% annually — a strong growth profile.
- Astera Labs, Inc. Common Stock converts about 34% of revenue into free cash flow — strong cash generation.
- Company is effectively debt-free after netting cash.
- Astera Labs, Inc. Common Stock posted a net loss in 1 of 2 available completed fiscal years (2024–2025).
- At a valuation score of 15/100, ALAB trades at a premium to its historical multiples (P/E 231.2).
See how ALAB ranks on the Capex Tracker — top 50 capital spenders compared.
Recent Market Moves
See all ALAB moves →| Date | Session | Price | Move | Z-Score |
|---|---|---|---|---|
| Sep 21 | Pre-market | 313.49 | +3.38% | 2.25 |
| Sep 21 | Regular | 342.25 | +12.86% | 8.57 |
| Sep 21 | After-hours | 341.50 | +12.61% | 8.41 |
Frequently Asked Questions about ALAB
Is ALAB stock a buy right now?
PreMarketPrice's quantitative model rates Astera Labs, Inc. Common Stock's financial health at 100/100 — Mimoriadne finančné zdravie a vysokú ziskovosť spoločnosti ALAB aktuálne znehodnocuje extrémne drahé ocenenie s FCF výnosom na úrovni iba 0,6 %.. This is a data-driven snapshot of fundamentals, not investment advice.
Is ALAB stock overvalued?
Astera Labs, Inc. Common Stock trades at a trailing P/E of 231.2 and our valuation score rates it 15/100 (higher = cheaper vs. its own history). See the Valuation History and Key Metrics sections for forward P/E, EV/EBITDA and PEG context.
When does Astera Labs, Inc. Common Stock report earnings?
No confirmed earnings date is currently scheduled for ALAB. The Earnings section lists recent reports and updates as dates are announced.
What sector does Astera Labs, Inc. Common Stock operate in?
Astera Labs, Inc. Common Stock operates in the Technology sector, within the Semiconductors & Related Devices industry. The Related Stocks section lists sector peers for comparison.
What does Astera Labs, Inc. Common Stock do?
Astera Labs Inc designs and delivers semiconductor-based connectivity solutions for cloud and AI infrastructure.
About Astera Labs, Inc. Common Stock (ALAB) Stock
Astera Labs, Inc. Common Stock (ALAB) is a US-listed stock operating in the Technology sector, specifically the Semiconductors & Related Devices industry. Real-time pricing data for Astera Labs, Inc. Common Stock is available on this page with a market capitalization of $59.3 billion. The financial health score for ALAB is 100/100, which indicates excellent financial strength based on profitability, leverage, liquidity, and growth metrics. This page provides real-time pre-market pricing, earnings calendar, financial health analysis, and valuation metrics for ALAB stock.
ALAB Stock Analysis & Key Metrics
On PreMarketPrice, you can track Astera Labs, Inc. Common Stock (ALAB) across multiple dimensions:
- Pre-market price & movement: Real-time ALAB stock price with percentage change, updated continuously during pre-market and regular trading hours.
- Valuation & P/E history: Historical P/E, P/S, and P/B ratios for ALAB with trend analysis and normalized valuation multiples.
- Financial statements: Revenue, net income, assets, liabilities, and equity for Astera Labs, Inc. Common Stock across multiple reporting periods.
- Financial health score: A composite score of 100/100 based on Altman Z-Score, Piotroski F-Score, profitability, and leverage metrics for ALAB.
- Sector peers: Compare ALAB against 10 other technology stocks on key financial metrics.
Is ALAB a Good Stock to Buy?
This page provides data-driven analysis to help you evaluate Astera Labs, Inc. Common Stock (ALAB) as an investment. The financial health score of 100/100 suggests excellent financial fundamentals. Valuation metrics show whether the stock is trading above or below its historical average.However, this is not financial advice — always do your own research before investing.
Data on this page is sourced from real-time market feeds, Polygon.io, and Finnhub.Astera Labs, Inc. Common Stock (ALAB) trades on NYSE/NASDAQ. Pre-market trading occurs 4:00 AM – 9:30 AM ET. Regular market hours are 9:30 AM – 4:00 PM ET.